In the last 50 years, the main approaches for treating myelodysplastic syndromes or acute myeloid leukemia have not changed. The Kousteni lab aims to change that.
Which patients respond less well to radiation therapy and why? Find out how the Spina lab is approaching this problem from the perspective of the immune system.
In Notes from the Lab, we spotlight the Giancotti lab and new research identifying factors that sustain prostate cancer cells that have become resistant to androgen receptor (AR) therapy.
In a new content series, Notes from the Lab, we spotlight research by the Piero Dalerba lab that aims to predict resistance to immunotherapy in certain colon cancers.